Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
early-stage
Biotech
With ph. 1 data, Aura has an eye on early-stage bladder cancer
Aura’s viruslike drug conjugate bel-sar and light activation completely eradicated the tumors of four out of five patients with low-grade disease.
Darren Incorvaia
Oct 17, 2024 4:05pm
Curie.Bio fuels up with $380M for biotech founders
Jun 26, 2024 10:45am
Sofinnova bulks out VC shop with a hefty $548M
Oct 19, 2021 6:25am
Rapha Capital Management launches $100M life science VC fund
Apr 16, 2021 8:50am
Advent raises $215M to nurture another troop of biotechs
Feb 18, 2021 2:00am
A16z unveils $750M biotech, healthcare fund
Feb 4, 2020 6:00am
